Evaluation of insulin detemir in combination with OADs [oral antidiabetic drugs] in type 2 diabetes mellitus
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Insulin detemir (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 01 Jul 2009 Actual end date (Dec 2004) added as reported by ClinicalTrials.gov.
- 01 Jul 2009 Actual patient number (132) added as reported by ClinicalTrials.gov.